MTLC Polyclonal Antibody, APC-Cy7 Conjugated
Product Specifications
Background
May regulate certain MYC target genes, MYC seems to be a direct upstream transcriptional activator. Does not seem to significantly affect growth cell capacity. Overexpression seems to mediate many of the known phenotypic features associated with MYC, including promotion of apoptosis, alteration of morphology, enhancement of anchorage-independent growth, tumorigenic conversion, promotion of genomic instability, and inhibition of hematopoietic differentiation (By similarity) .
Synonyms
MTLC; Myc target protein 1; Myc target in myeloid cells protein 1; MYCT1; MTMC1
Gene ID
80177
Swiss Prot
Q8N699
Cellular Locus
Nucleus
Host
Rabbit
Cross Reactivity
Human, Mouse
Immunogen
21-100/235
Target
MTLC
Clonality
Polyclonal
Isotype
IgG
Conjugation
APC-Cy7
Source
KLH conjugated synthetic peptide derived from human MTLC
Applications
WB, IF (IHC-P), IF (IHC-F), IF (ICC)
Purification
Purified by Protein A.
Excitation Emission
650nm/780nm
Concentration
1µg/µl
Dilution
WB (1:300-5000), IF (IHC-P) (1:50-200), IF (IHC-F) (1:50-200), IF (ICC) (1:50-200)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
80177
Predicted Cross Reactivity
Rat, Dog
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15308450 1 Vial
Lentiviral human TWISTNB shRNA (UAS) - Lentiviral human TWISTNB shRNA (UAS, RFP) (25)
Ask
View Details 